Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px
Document › Details

Qiagen N.V.. (4/25/12). "Press Release: Qiagen Makes Organizational and Leadership Changes (AD HOC Announcement According to §15 WpHG)". Venlo.

Organisations Organisation Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA)
  Group Qiagen (Group)
  Organisation 2 Qiagen GmbH
  Group Qiagen (Group)
Products Product reagents (bio/biochemical)
  Product 2 molecular diagnostics
Persons Person Lubenow, Helge (Qiagen 201207– promoted SVP Molecular Diagnostics at Qiagen since 1997 before VP MDx Marketing)
  Person 2 Hauffe, Dietrich (Bruker 201508– EVP Life Sciences Mass Spectrometry at Bruker Daltonics before Qiagen + Dionex)
     


QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it was making organizational changes designed to capture opportunities and further improve its capabilities to address the needs of its customers.

Two new Business Areas - Molecular Diagnostics and Life Sciences - will be created as of July 1 under the leadership of new Executive Committee (EC) members. Dr. Helge Lubenow, who has been with QIAGEN since 1997 and currently serves as Vice President, Molecular Diagnostics Marketing, has been appointed Senior Vice President, Molecular Diagnostics Business Area, and a member of the EC. Dr. Dietrich Hauffe, who has been with QIAGEN since 2010 (also from 1997-2000) and currently serves as Vice President, Life Sciences Marketing, has been appointed Senior Vice President, Life Sciences Business Area, and a member of the EC.

Dr. Joachim Schorr, Managing Director, Senior Vice President Global Research and Development, has decided to leave the company but has been retained as a consultant. The responsibilities of Dr. Schorr, who will leave QIAGEN during the second quarter of 2012, will be assumed by the R&D leaders of the Business Areas.

QIAGEN's Executive Committee will now be comprised of the following members: Peer M. Schatz (CEO); Dietrich Hauffe (Life Sciences Business Area, new); Douglas Liu (Operations); Helge Lubenow (Molecular Diagnostics Business Area, new); Roland Sackers (CFO); Ulrich Schriek (Business Development); Thomas Schweins (Human Resources, Corporate Strategy and Marketing Services); and Bernd Uder (Commercial Operations).


Contacts QIAGEN N.V.:

Investor Relations
John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com

Public Relations
Dr. Thomas Theuringer, Tel: +49 2103 29 11826; pr@qiagen.com

   
Record changed: 2017-04-02

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Qiagen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe 2019 Hamburg Germany BEU2019 650x80px




» top